- Edenred‘s Ebitda for the first half of 2024 reached €597 million, a 24% increase year-on-year, and surpassed the estimate of €587.3 million.
- Organic Ebitda grew by 26.2%.
- The Ebitda margin was 42.8%, slightly higher than the estimated 42.3%.
- Revenue for the first half stood at €1.40 billion, a 19% rise year-on-year, and exceeded the estimate of €1.39 billion.
- Like-for-like revenue increased by 18.3%, better than the estimated 18%.
- Operating revenue was €1.27 billion, a 16% increase year-on-year, meeting the estimate of €1.27 billion.
- Benefits and engagement operating revenue reached €821 million, up 21% year-on-year, slightly below the estimated €827.3 million.
- Mobility operating revenue was €311 million, a 9.9% increase year-on-year but below the estimated €315.4 million.
- Complementary solutions operating revenue came in at €139 million, a 2.2% increase year-on-year, just below the estimate of €139.3 million.
- Like-for-like operating revenue increased by 15.4%, near the estimated 16%.
- Benefits and engagement operating revenue, like-for-like, went up by 15.6%.
- Mobility operating revenue, like-for-like, grew by 21%.
- Complementary solutions revenue, like-for-like, increased by 2.9%.
- Ebit reached €488 million, up 22% year-on-year, and surpassed the estimate of €479.5 million.
- Net income was €235 million, a 16% increase year-on-year, above the estimate of €229.3 million.
- Second quarter operating revenue was €646 million, a 14% increase year-on-year, but slightly below the estimate of €648.3 million.
- Second quarter like-for-like operating revenue grew by 14%, close to the estimated 14.7%.
- Second quarter revenue reached €710 million, up 16% year-on-year, surpassing the estimate of €708.8 million.
- Second quarter like-for-like revenue increased by 16.3%, better than the estimated 16%.
- Edenred forecasts Ebitda for the full year to be between €1.23 billion and €1.30 billion, aligning with the estimate of €1.26 billion.
- The company still expects total revenue to exceed €5 billion by 2030.
Edenred on Smartkarma
Analysts on Smartkarma, such as Value Investors Club, have been covering Edenred, a global payment solutions company. In a recent report titled “Edenred Se (EDEN) – Friday, Apr 19, 2024,” the analyst highlighted Edenred‘s strong financial performance and leading position in the industry. Despite a stock decline of -19.50% year-to-date due to a legal investigation in Italy, analysts view Edenred as a long-term opportunity for investors. The company’s robust balance sheet, cash flow generation, and growth potential are cited as factors supporting this positive outlook.
A look at Edenred Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 0 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 2 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 2.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Edenred, a company that provides prepaid vouchers for various products and services, has received a mixed outlook based on Smartkarma Smart Scores. With a Dividend and Growth score of 3, Edenred shows promise in terms of potential dividend returns and future growth opportunities. However, the company’s Value, Resilience, and Momentum scores are relatively lower at 0, 2, and 2 respectively, indicating areas that may need improvement.
Despite facing challenges in terms of valuation, resilience, and momentum, Edenred‘s strengths lie in its ability to offer attractive dividends and opportunities for growth. By focusing on enhancing its value proposition, improving resilience to market fluctuations, and building positive momentum, Edenred can work towards securing a more robust long-term outlook in the prepaid vouchers market, where it rewards employees and loyal customers with vouchers for a variety of products and services.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
